Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02156817 · ClinicalTrials.gov registry record
Neurophysiologic Maturation Index for Late Preterm Infants
A clinical trial, sponsored by Brown University.
- Completed
- Registry status
- 26
- Enrollment target
NCT02156817: Completed study, sponsored by Brown University.
NCT02156817 is a clinical trial that has completed, run by Brown University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02156817 has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Late preterm infants contribute to significant neonatal intensive care unit health care resource utilization because of their sheer numbers. Determinants of the length of hospitalization (LOH) in this population are understudied. Gestational age (GA) is used most commonly as a predictor for LOH but there are many limitations including inaccurate dating and morbidities of prematurity which at least partly related to neurophysiological immaturity. The latter can be assessed by amplitude integrated electroencephalogram (aEEG, a simplified 5 lead EEG), and possibly by heart rate variability (HRV) and respiratory variability (RV). All 3 are non-invasive tests that can be done at the bedside. Our study hypothesis is to determine if neurophysiologic maturation as assessed by aEEG, HRV and RV within 24-96 hours following birth improves the correlation between gestational age and length of hospitalization compared to gestational age alone.
Primary Outcome
linear regression model: LOH = intercept + b1GA + b2aEEG + b3HRV + b4RV + error term; b1 - b4 represents the weight of each variable to explain the variance of the equation (R2), GA is gestational age, aEEG is amplitude integrated EEG, HRV is heart rate variability, RV is respiratory variability, LOH is length of hospital stay
Interventions
- OTHER Amplitude integrated electroencephalogram, Cardiorespiratory signal acquisition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-03 |
| Est. Completion | 2017-06-02 |
What the finished NCT02156817 record still lists
NCT02156817 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Amplitude integrated electroencephalogram, Cardiorespiratory signal acquisition is the first listed.
NCT02156817 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02156817 about?
NCT02156817 is a clinical study titled "Neurophysiologic Maturation Index for Late Preterm Infants". Late preterm infants contribute to significant neonatal intensive care unit health care resource utilization because of their sheer numbers. Determinants of the length of hospitalization (LOH) in this population are understudied. Gestational age (GA) is used most commonly as a predictor for LOH but ...
What is the current status of trial NCT02156817?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2014-03. Estimated completion is 2017-06-02.
What interventions are being tested in trial NCT02156817?
The interventions under investigation include: Amplitude integrated electroencephalogram, Cardiorespiratory signal acquisition (OTHER).
Who is sponsoring clinical trial NCT02156817?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia